ClinicalTrials.gov
public full text
Public Domain
Study to Explore the Relationship Between the Level of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device Against Existing Measures of Lung Disease
A cross-sectional, observational study of EBC H2O2 levels, as measured by a novel device, 'Inflammacheck™', and other markers of disease severity and symptom control in patients with Asthma and COPD and volunteers with no history of lung disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- EXhaled Hydrogen Peroxide As a Marker of Lung diseasE (EXHALE) Pilot Study.#811825
- Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in Asthma#851392
- Fractional Exhaled Nitric Oxide and Exacerbations of COPD#1074890
- Vivatmo proTM EU-study: FeNO Monitoring in Asthmatic Patients Responding to ICS Treatment#893091
- The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms#1103177
Record · ID 1432140
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive